Case Overview
Our client is a PhD-level researcher with over 10 years of experience in biopharmaceutical research. During postdoctoral and senior research positions at U.S. research institutions, the client contributed to the discovery of novel targets in tumor immunotherapy, accumulating 500+ citations, 15 first-author / corresponding-author papers, and over 20 peer-review activities with international journals.
While maintaining H-1B status, the client approached Song Law Firm to evaluate eligibility for EB-1A (Alien of Extraordinary Ability) first-preference permanent residency.
Legal Issues
EB-1A requires meeting at least three of USCIS’s ten regulatory criteria plus demonstrating “sustained national or international acclaim.” Citation counts alone frequently lead to denials at the Final Merits Determination stage, so the key was building qualitative evidence under each criterion.
Three issues were central: (1) whether peer-review service established the “Judging the Work of Others” criterion; (2) whether 500 citations demonstrated excellence above field average; (3) whether 15 first-author papers extended beyond “Scholarly Articles” to carry decisive weight at Final Merits.
Song Law Firm Strategy
Our immigration team approached this systematically:
1. Ten-Criteria Mapping — We mapped the client’s record 1:1 to the ten EB-1A criteria, securing 2-3 independent pieces of evidence per criterion. We satisfied five criteria clearly: judging, scholarly articles, media coverage, expert letters, and leading/critical role.
2. Field Benchmark Data — We submitted supplementary Field-Weighted Citation Impact analysis from Clarivate and Scopus showing the client’s 500 citations ranked in the top percentile for the immunotherapy sub-field — 4.2× the field average.
3. Reference Letter Quality — We obtained letters from seven renowned professors across the U.S., Europe, and Asia, coordinating in advance so each letter addressed a different criterion. We removed “casual acquaintance” language and focused on independent expert evaluations.
4. Final Merits Narrative — Under the two-step Kazarian framework (criteria satisfaction → sustained acclaim), we foregrounded the second step. Rather than listing criteria, we constructed a narrative around national-security and public-health impact to facilitate holistic review.
Outcome
The I-140 EB-1A petition was approved on first review without any RFE. Processing time with Premium Processing was 15 days. Song Law Firm then handled the subsequent I-485 adjustment of status, securing full permanent residency.
Lessons
EB-1A adjudication is narrative design, not number stacking. Citations, papers, and peer-review service are only raw materials — success comes from rearranging evidence so adjudicators holistically conclude “this person is in the small percentage at the top of the field.” Song Law Firm drives Final Merits decisions through field benchmark data and coordinated expert letters.
This I-797 Notice of Action is from an actual case handled and approved by Song Law Firm. All client personal information has been fully redacted.
Consult with Song Law Firm
For specialized immigration and visa counsel, please contact Song Law Firm.
- Phone: 201-461-0031
- Email: mail@songlawfirm.com
- Website: songlawfirm.com
- Offices: New Jersey · New York · Georgia · Texas · Massachusetts
※ This success story is published with the client’s consent and has been anonymized. Prior results do not guarantee similar outcomes. Individual results depend on the specific facts of each case. For legal advice, please consult a licensed attorney directly. Compliant with NJ Rules of Professional Conduct 7.1.
